HANSON & DOREMUS INVESTMENT MANAGEMENT – SPDR S&P Biotech ETF Transaction History
HANSON & DOREMUS INVESTMENT MANAGEMENT portfolio value:
$1.59M
portfolio value
HANSON & DOREMUS INVESTMENT MANAGEMENT quarter portfolio value change:
+6.80%
quarter
SPDR S&P Biotech ETF 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +28.61% | 4.46K shares | 433K | $79.32 | 20.08K |
| Q2 2022 | share | Increase | +18.20% | 2.40K shares | -28K | $74.27 | 15.61K |
| Q1 2022 | share | Increase | +12.54% | 1.47K shares | -127K | $89.88 | 13.21K |
| Q4 2021 | share | Increase | +10.28% | 1.09K shares | -23K | $113.24 | 11.74K |
| Q3 2021 | share | Increase | +23.92% | 2.05K shares | 381K | $125.71 | 10.64K |
| Q2 2021 | share | Decrease | -8.13% | -760 shares | -312K | $135.4 | 8.59K |
| Q1 2021 | share | Increase | +6.01% | 530 shares | 27K | $135.65 | 9.35K |
| Q4 2020 | share | Increase | +2.68% | 230 shares | 285K | $140.74 | 8.82K |
| Q3 2020 | share | Increase | +20.49% | 1.46K shares | 159K | $111.27 | 8.59K |
| Q2 2020 | share | Decrease | -1.29% | -93 shares | 239K | $111.7 | 7.13K |
| Q1 2020 | share | Increase | +28.59% | 1.60K shares | 25K | $77.26 | 7.22K |
| Q4 2019 | share | Increase | +28.88% | 1.25K shares | 202K | $94.88 | 5.61K |
| Q3 2019 | share | Increase | +3279.07% | 4.23K shares | 321K | $76.07 | 4.35K |
| Q2 2019 | share | Increase | 0.00% | 129 shares | 11K | $87.5 | 129 |